Macrophage‐dependent, NK‐cell‐independent “natural” surveillance of tumours in syngeneic mice
暂无分享,去创建一个
[1] A. Greenberg,et al. Murine natural anti‐tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice , 1979, International journal of cancer.
[2] U. Dular,et al. Surface membrane changes of T cells induced by syngeneic tumour cells. II. T‐cell defects induced by small tumour cell inocula or tumour cell antigens , 1978, International journal of cancer.
[3] U. Dular,et al. Surface membrane changes of T cells induced by syngeneic tumour cells. I. Formation and uptake of complexes of Ig and tumour antigens by T cells , 1978, International journal of cancer.
[4] H. Morris,et al. Growth of transplanted rat tumors following administration of cell-free tumor antigens. , 1978, Cancer research.
[5] G. Klein,et al. Mouse natural killer (NK) cell activity against human cell lines is not influenced by superinfection of the target cell with xenotropic murine c‐type virus , 1978, International journal of cancer.
[6] O. Haller,et al. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo , 1977, Nature.
[7] P. Hochman,et al. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts. , 1977, Journal of immunology.
[8] M. Brunda,et al. Antibodies to bacterial and tumor-derived antigens in sera from normal guinea pigs. , 1977, Journal of immunology.
[9] G. Shearer,et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts , 1977, European journal of immunology.
[10] J. Durdik,et al. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG. , 1977, Journal of immunology.
[11] C. Henney,et al. BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates. , 1977, Journal of immunology.
[12] S. Russell,et al. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas. , 1977, Journal of immunology.
[13] S. Ménard,et al. Natural anti‐tumor serum reactivity in balb/c mice. I. Characterization and interference with tumor growth , 1977, International journal of cancer.
[14] G. Edelman,et al. Isolation by cell-column chromatography of immunoglobulins specific for cell surface carbohydrates , 1977, The Journal of experimental medicine.
[15] R. Keller. Promotion of tumor growth in vivo by antimacrophage agents. , 1976, Journal of the National Cancer Institute.
[16] M. Greene,et al. Non-adaptive rejection of small tumour inocula as a model of immune surveillance , 1976, Nature.
[17] R. Kerbel,et al. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas. , 1976, Journal of the National Cancer Institute.
[18] H. Peter,et al. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator. , 1976, Journal of immunology.
[19] N. Pellis,et al. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection. , 1975, Journal of immunology.
[20] A. Fox,et al. The effect of T lymphocyte deficiency on tumor induction and growth. , 1975, Cellular immunology.
[21] A. Greenberg,et al. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay. , 1975, Immunology.
[22] E. Boyse,et al. Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells. , 1975, Journal of the National Cancer Institute.
[23] R. Herberman,et al. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity , 1975, International journal of cancer.
[24] E. Wheelock,et al. Effects of intravenous silica on immune and non-immune functions of the murine host. , 1975, Journal of immunology.
[25] M. L. Karnovsky,et al. BIOCHEMICAL CHARACTERISTICS OF ACTIVATED MACROPHAGES * , 1975, Annals of the New York Academy of Sciences.
[26] S. Martin,et al. Anti‐tumor antibodies in normal mouse sera , 1975, International journal of cancer.
[27] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.
[28] J. Haskill,et al. Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas. , 1975, Journal of the National Cancer Institute.
[29] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.
[30] A. Allison,et al. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice , 1974, Nature.
[31] P. De Somer,et al. Induction of polyoma tumors in athymic nude mice , 1974, International journal of cancer.
[32] O. Stutman. Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice , 1974, Science.
[33] J. Playfair,et al. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. , 1974, Clinical and experimental immunology.
[34] H. Festenstein,et al. Specific cytostatic effect of lymph node cells from normal and T cell‐deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor‐bearing mice , 1973, European journal of immunology.
[35] L. Old,et al. SOME BIOCHEMICAL PROPERTIES OF THYMUS LEUKEMIA ANTIGENS SOLUBILIZED FROM CELL MEMBRANES BY PAPAIN DIGESTION , 1973, The Journal of experimental medicine.
[36] B. Rouse,et al. Anti-θ Serum-indueed Suppression of the Cellular Transfer of Tumour-specific Immunity to a Syngeneic Plasma Cell Tumour , 1972 .
[37] R. Herberman,et al. IMMUNE AND NATURAL ANTIBODIES TO SYNGENEIC MURINE PLASMA CELL TUMORS , 1972, The Journal of experimental medicine.
[38] E. Simpson,et al. Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. , 1971, Clinical and experimental immunology.
[39] L. Israels,et al. Cell surface associated gamma globulins in lymphocytes. I. Reverse immune cytoadherence: a technique for their detection in mouse and human lymphocytes. , 1971, Journal of immunology.
[40] F. Burnet. The concept of immunological surveillance. , 1970, Progress in experimental tumor research.
[41] M. Chu,et al. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). , 1968, Biochemical pharmacology.
[42] C. E. Thomas,et al. Virus-like Particles in Murine Leukaemia L5178Y , 1967, Nature.
[43] R. Schindler,et al. In vitro studies of cell-bound immunity; cloning assay of the cytotoxic action of sensitized lymphoid cells on allogeneic target cells. , 1966, Immunology.
[44] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[45] J. Furth,et al. On the Role of Thymus, Spleen, and Gonads in the Development of Leukemia in a High-Leukemia Stock of Mice , 1944 .